尿激酶原溶栓联合急诊经皮冠状动脉介入术对ST段抬高型心肌梗死患者的影响

李妮妮; 周永峰

doi:10.7619/jcmp.202018008

尿激酶原溶栓联合急诊经皮冠状动脉介入术对ST段抬高型心肌梗死患者的影响

李妮妮¹,
周永峰^2, ,

1. 延安大学咸阳医院心血管内科三病区, 陕西咸阳, 712000;
2. 陕西省榆林市星元医院心血管内一科, 陕西榆林, 719000

详细信息

通讯作者:
周永峰, E-mail: 306976289@qq.com

中图分类号: R542.2
计量
- 文章访问数: 438
- HTML全文浏览量: 105
- PDF下载量: 11
出版历程
- 收稿日期: 2020-07-29

Effect of urokinase thrombolysis combined with emergency percutaneous coronary intervention in patients with ST segment elevation myocardial infarction

LI Nini¹,
ZHOU Yongfeng^2, ,

1. Third Ward of Cardiovascular Medicine, Xianyang Hospital of Yan'an University, Xianyang, Shaanxi, 712000;
2. First Cardiovascular Department, Xingyuan Hospital of Yulin City in Shaanxi Province, Yulin, Shaanxi, 719000

摘要

摘要: 目的探讨尿激酶原溶栓联合急诊经皮冠状动脉介入术(PCI)对急性ST段抬高型心肌梗死(STEMI)患者的影响。方法将150例STEMI患者随机分为对照组和观察组,每组75例。对照组采用急诊PCI治疗,观察组采用尿激酶原溶栓联合急诊PCI治疗。比较2组心肌梗死溶栓试验(TIMI)血流分级、心肌灌注和心功能水平。结果术后,观察组TIMI 血流分级为3级的患者比率为85.33%, ST段回落患者比率为90.67%, TIMI心肌灌注分级(TMPG)3级患者比率为68.00%, 分别高于对照组的69.33%、72.00%、52.00%; TIMI帧数(CTFC)低于对照组,差异有统计学意义(P<0.05)。术后1、3个月,观察组左心室舒张末期内径(LVEDD)低于对照组,左心室射血分数(LVEF)高于对照组,差异有统计学意义(P<0.05)。结论采用尿激酶原溶栓联合急诊PCI治疗可改善急性STEMI患者心肌微循环血流灌注和心功能。
- 尿激酶 /
- 经皮冠状动脉介入术 /
- ST段抬高型心肌梗死 /
- 心肌灌注
Abstract: Objective To investigate the effect of urokinase thrombolysis combined with percutaneous coronary intervention(PCI)in patients with acute ST segment elevation myocardial infarction(STEMI). Methods A total of 150 STEMI patients were randomly divided into control group and observation group, with 75 cases in each group. The control group was treated with emergency PCI, while the observation group was treated with urokinase thrombolysis combined with emergency PCI. Blood grading of thrombolysis in myocardial infarction(TIMI), myocardial perfusion and cardiac function levels of the two groups were compared in the two groups. Results Ratio of patients with the TIMI level 3 blood flow in the observation group was 85.33%, ratio of patients with the ST-segment regression was 90.67%, and ratio of patients with the TMPG level 3 blood flow was 68.00%, which were higher than those in the control group(69.33%, 72.00% and 52.00%, respectively); the Corrected TIMI Frame Count(CTFC)was significantly lower than the control group(P<0.05). At 1 and 3 months after surgery, the left ventricular end-diastolic diameter(LVEDD)in the observation group was significantly lower than that in the control group, and the left ventricular ejection fraction(LVEF)was significantly higher than that in the control group(P<0.05). Conclusion Thrombolytic therapy by urokinase combined with emergency PCI can improve myocardial microcirculation perfusion and cardiac function in patients with acute STEMI.
- urokinase /
- percutaneous coronary intervention /
- ST segment elevation myocardial infarction /
- myocardial perfusion

HTML全文

参考文献(15)

陈存芳, 贾博, 徐绍辉, 等. 经血栓抽吸导管注射重组人尿激酶原对高血栓负荷ST段抬高型心肌梗死患者急诊介入治疗效果的影响[J]. 临床心血管病杂志, 2019, 35(1): 75-78.

李丽娟, 余晓洋. 经皮冠状动脉介入术中尿激酶联合尼可地尔对急性ST段抬高心肌梗死患者的临床研究[J]. 中国临床药理学杂志, 2019, 35(22): 2786-2789.

王学斌, 赵良平, 徐卫亭, 等. 强化他汀治疗对急性ST段抬高型心肌梗死患者急诊经皮冠状动脉介入治疗术后近期预后的效果研究[J]. 中国全科医学, 2018, 21(26): 3164-3169

, 3174.

白文楼, 陈涛, 孟存良, 等. 比伐芦定联合重组人尿激酶原对老年急性心肌梗死患者直接PCI术后慢血流/无复流的影响及安全性[J]. 临床心血管病杂志, 2019, 35(7): 595-599.

苍春阳, 姜春玉. 阿替普酶治疗ST段抬高型心肌梗死患者的临床研究[J]. 中国临床药理学杂志, 2019, 35(16): 1727-1730.

吴方辉, 张江武, 刘金来, 等. 提前肝素化和超选择冠状动脉内注入替罗非班对STEMI患者PCI的影响[J]. 中国现代医学杂志, 2019, 29(7): 92-96.

邓学军, 谭震, 余冬梅, 等. 地尔硫(艹)/卓联合肾上腺素对急性ST段抬高型心肌梗死患者冠脉介入无复流的影响[J]. 临床心血管病杂志, 2018, 34(2): 116-119.

杨英, 杨简, 刘晓雯, 等. 急性ST段抬高型心肌梗死患者急诊PCI术后短期不良心血管事件发生情况及其影响因素[J]. 山东医药, 2018, 58(40): 10-14.

卢婷, 陶贵周. 前列地尔对直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者心肌灌注的影响[J]. 中国动脉硬化杂志, 2019, 27(4): 337-343.

徐雷, 安少波, 杜晓静, 等. PPCI术联合尿激酶原及尼可地尔对ST段抬高型心肌梗死患者的疗效观察[J]. 中国新药杂志, 2018, 27(14): 1625-1630.

杨汆, 胡文志, 王迪斌, 等. STEMI患者PCI术前预注射尼可地尔对无复流的预防作用[J]. 临床心血管病杂志, 2019, 35(4): 335-339.

彭虹, 廖鑫, 梁霄, 等. 急性ST段抬高型心肌梗死患者急诊PCI后应用卡泊酸对左心室重构的影响[J]. 山东医药, 2018, 58(22): 50-53.

郑望, 邓兵, 沈琳, 等. 重组人尿激酶原联合替罗非班在高血栓负荷急性ST段抬高型心肌梗死患者急诊经皮冠状动脉介入治疗中的应用效果[J]. 实用心脑肺血管病杂志, 2018, 26(5): 91-93

, 98.

吴多益, 许和平, 孙娟, 等. 急性心肌梗死后就诊延迟患者冠状动脉微血管阻塞的影响因素及临床结局研究[J]. 中国全科医学, 2019, 22(13): 1592-1597.

王小虎, 周晗. 小剂量尿激酶溶栓联合经皮冠状动脉介入术治疗ST段抬高型心肌梗死疗效观察[J]. 新乡医学院学报, 2018, 35(9): 820-823.

施引文献(3)

期刊类型引用(3)

1.	张建国. PCI前冠状动脉内溶栓治疗急性ST段抬高型心肌梗死患者的效果. 中国民康医学. 2023(04): 25-28 . 百度学术
2.	张红霞，武金敏，李盼盼. PCI前行静脉溶栓治疗对急性ST段抬高型心肌梗死患者的影响. 宁夏医学杂志. 2023(05): 445-447 . 百度学术
3.	黄春，李岳，迪力·热巴. 尿激酶原溶栓联合经皮冠状动脉介入术治疗ST段抬高型心肌梗死的效果研究. 中国医学创新. 2021(28): 37-41 . 百度学术